Methylxanthines, inflammation, and cancer: Fundamental mechanisms

23Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Methylxanthines are an integral part of everyday food and drink consumption even though the majority of humans do not identify them by their chemical name. The breakthrough in understanding the action(s) of methylxanthines was in large part due to the understanding that methylxanthines can function as antagonists of adenosine receptors. This represented an example of scientific search and was instructive in view of both new therapeutic options and alarming realizations. It was the subsequent demonstration of the in vivo critical role of A2A adenosine receptors in controlling excessive collateral inflammatory damage that attracted the attention of immunologists to the A2A-adenosine-receptor- antagonizing methylxanthines. We summarize here data showing that caffeine is capable of preventing the inhibition of antitumor T cells in a hypoxic tumor microenvironment. On the other hand, caffeine may exacerbate liver damage by weakening the tissue-protecting A2A adenosine receptor signaling during episodes of acute liver inflammation. However, methylxanthines may also prevent the excessive hepatic connective tissue deposition that is associated with the progression of chronic hepatitis to cirrhosis, which is one of the common causes of mortality. © 2011 Springer Berlin Heidelberg.

Cite

CITATION STYLE

APA

Ohta, A., & Sitkovsky, M. (2011). Methylxanthines, inflammation, and cancer: Fundamental mechanisms. Handbook of Experimental Pharmacology. https://doi.org/10.1007/978-3-642-13443-2_19

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free